Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
<p>Abstract</p> <p>Background</p> <p>Neuroblastoma is a childhood cancer derived from immature cells of the sympathetic nervous system. The disease is clinically heterogeneous, ranging from neuronal differentiated benign ganglioneuromas to aggressive metastatic tumours...
Main Authors: | Tømte Ellen, Buechner Jochen, Haug Bjørn, Henriksen Jørn R, Løkke Cecilie, Flaegstad Trond, Einvik Christer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | BMC Developmental Biology |
Online Access: | http://www.biomedcentral.com/1471-213X/11/1 |
Similar Items
-
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
by: Peter Utnes, et al.
Published: (2019-03-01) -
The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
by: Danny Misiak, et al.
Published: (2021-05-01) -
Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression
by: Terutaka Tanimoto, et al.
Published: (2020-09-01) -
MYCN Function in Neuroblastoma Development
by: Jörg Otte, et al.
Published: (2021-01-01) -
Analysis of the MYCN amplicon in neuroblastoma
by: Kenyon, Rebecca Margaret
Published: (1996)